EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Cholesteryl Ester Transfer Protein Deficiency and Hyperalphalipoproteinemia

Akihiro Inazu

Journal of Atherosclerosis and Thrombosis · 2025

DOI: 10.5551/jat.rv22037 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Atherosclerosis and Thrombosis, 2025. Verfasst von Akihiro Inazu. Beteiligte Einrichtung: Department of Clinical Laboratory Science, Graduate School of Medical Science, Kanazawa University. Hauptthemen laut MEDLINE: Cholesterol Ester Transfer Proteins, Hyperlipoproteinemias, Cholesterol Ester Storage Disease, Atherosclerosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cholesteryl ester transfer protein (CETP) deficiency and lipoprotein phenotypes with CETP inhibitors were compared. The effects on atherosclerotic cardiovascular disease (ASCVD) and the recently suggested retinal disease of age-related macular degeneration (ARMD) were summarized and discussed in relation to CETP deficiency and extremely increased high-density lipoprotein (HDL) cholesterol levels (>100 mg/dL). In CETP truncated variants leading to reduced low-density lipoprotein cholesterol levels, ASCVD risk was decreased in heterozygotes. ASCVD prevalence did not increase in homozygotes with CETP deficiency. However, the association between ASCVD and ARMD risks in cases of very high HDL cholesterol level found in multifactorial hyperalphalipoproteinemia needs to be clarified on an etiological basis. The hurdles facing the development of CETP inhibitors are summarized, including a new result for obicetrapib.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholesterol Ester Transfer ProteinsHyperlipoproteinemiasCholesterol Ester Storage DiseaseAtherosclerosisHumansCholesterol, HDLMacular DegenerationLipid Metabolism, Inborn Errors

Stichwörter der Autor:innen

Age-related macular degeneration (ARMD)ApoC3-rich HDLApoE-rich HDLAtherosclerotic cardiovascular disease (ASCVD)Cholesteryl ester transfer protein (CETP)Coronary artery disease (CAD)D459G variantHDL-TGHyperalphalipoproteinemia (HALP)Lipoprotein(a) [Lp(a)]Major cardiovascular event (MACE)Proprotein convertase subtilisin/kexin 9 (PCSK9)Retinal pigment epithelium (RPE)Small dense LDL (sdLDL)

Substanzen

Cholesterol Ester Transfer ProteinsCETP protein, humanCholesterol, HDL

Autor:innen und Institutionen

  • Department of Clinical Laboratory Science, Graduate School of Medical Science, Kanazawa University.

Zitieren

APA

Inazu, A. (2025). Cholesteryl Ester Transfer Protein Deficiency and Hyperalphalipoproteinemia. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.rv22037

Vancouver

Inazu A. Cholesteryl Ester Transfer Protein Deficiency and Hyperalphalipoproteinemia. Journal of Atherosclerosis and Thrombosis. 2025. doi:10.5551/jat.rv22037

BibTeX
@article{Inazu2025,
  author = {Inazu, Akihiro},
  title = {Cholesteryl Ester Transfer Protein Deficiency and Hyperalphalipoproteinemia},
  journal = {Journal of Atherosclerosis and Thrombosis},
  year = {2025},
  doi = {10.5551/jat.rv22037}
}
Kostenlos starten →